Literature DB >> 19137

The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates.

J L Meyer, K E Lee, J H Bergert.   

Abstract

The effect of a number of structurally related multidentate organic phosphonates on the rate of crystal growth of calcium oxalate was studied as a function of pH. Rate constants were obtained at various concentrations for the phosphonates ethane-1-hydroxy-1,1-diphosphonate (EHDP), nitrilotri(methylenephosphonic acid) (NTMP), N,N,N',N'-ethylene-diaminetetra(methylenephosphonic acid) (ENTNP), and N,N,N',N'-hexamethylenediaminetetra(methylenephosphonic acid (HMTMP), at pH 5.00, 6.00, and 7.00. The effect of pH on the inhibitory activity of each of the phosphonates was considerable with effective concentrations of inhibitor decreasing two orders of magnitude, in some cases, as the pH was increased. At a given pH the potentially hexadentate ligands, ENTMP and HMTMP, were generally the most effective inhibitors. The results suggested that EHDP, at currently administered doses, provides only a moderate increase in the capacity of human urine to inhibit calcium oxalate crystal growth.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19137     DOI: 10.1007/BF02012770

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


  12 in total

1.  Growth of calcium oxalate crystals. I. A model for urinary stone growth.

Authors:  J L Meyer; L H Smith
Journal:  Invest Urol       Date:  1975-07

Review 2.  A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth.

Authors:  H Fleisch; R G Russell
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

3.  The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite.

Authors:  J L Meyer; G H Nancollas
Journal:  Calcif Tissue Res       Date:  1973-12-31

4.  The treatment of osteoporosis with disodium ethane-1, 1-diphosphonate.

Authors:  J Jowsey; B L Riggs; P J Kelly; D L Hoffman; P Bordier
Journal:  J Lab Clin Med       Date:  1971-10

5.  Complexes in calcium phosphate solutions.

Authors:  A Chughtai; R Marshall; G H Nancollas
Journal:  J Phys Chem       Date:  1968-01

6.  The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates.

Authors:  M D Francis
Journal:  Calcif Tissue Res       Date:  1969

7.  Effect of diphosphonate on crystallization of calcium oxalate in vitro.

Authors:  C Y Pak; M Ohata; K Holt
Journal:  Kidney Int       Date:  1975-03       Impact factor: 10.612

8.  Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

Authors:  R R Recker; P D Saville
Journal:  Toxicol Appl Pharmacol       Date:  1973-04       Impact factor: 4.219

9.  The influence of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats.

Authors:  D Fraser; R G Russell; O Pohler; W G Robertson; H Fleisch
Journal:  Clin Sci       Date:  1972-02       Impact factor: 6.124

10.  The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers.

Authors:  W G Robertson; M Peacock; R W Marshall; F Knowles
Journal:  Clin Sci Mol Med       Date:  1974-07
View more
  1 in total

Review 1.  Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders.

Authors:  Norbert Laube; Wolfgang Berg; Falk Bernsmann; Sascha Gravius; Florian Klein; Stefan Latz; Dirk von Mallek; Tadeusz Porowski; Thomas Randau; Anna Wasilewska; Christian Fisang
Journal:  EPMA J       Date:  2014-08-16       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.